Cell phone intervention to improve adherence: cystic fibrosis care team, patient, and parent perspectives
- PMID: 20054860
- PMCID: PMC2882089
- DOI: 10.1002/ppul.21164
Cell phone intervention to improve adherence: cystic fibrosis care team, patient, and parent perspectives
Abstract
Background: Treatment regimens for patients with cystic fibrosis (CF) are time-consuming and complex, resulting in consistently low adherence rates. To date, few studies have evaluated innovative technologies to improve adherence in this population. Current infection control guidelines for patients with CF seek to minimize patient-to-patient transmission of potential pathogens. Thus, interventions must avoid face-to-face contact and be delivered individually, limiting opportunities for peer support. This study aimed to develop and assess a web-enabled cell phone, CFFONE, designed to provide CF information and social support to improve adherence in adolescents with CF.
Methods: The acceptability, feasibility, and utility of CFFONE were evaluated with health care professionals (n = 17) adolescents with CF aged 11-18 years old (n = 12), adults with CF aged 21-36 years old (n = 6), parents of adolescents with CF (n = 12), and technology experts (n = 8). Adolescents also tested a prototype of CFFONE (n = 9). Qualitative and quantitative data were collected.
Results: Focus group data with health care professionals indicated a need for this intervention, and indicated that CFFONE would be likely to improve knowledge and social support, and somewhat likely to improve adherence. Adolescent, adults, and parents all rated CFFONE as likely to improve adherence. Technology experts rated the prototype design and format as appropriate.
Conclusions: The current study provided some support from key stakeholders for this intervention to improve adherence in adolescents with CF. Next steps include a multi-center trial of the efficacy and safety of CFFONE.
(c) 2010 Wiley-Liss, Inc.
References
-
- Cystic Fibrosis Foundation . Patient Registry 2006 Annual Report. Bethesda, MD: 2008.
-
- Quittner AL, Barker DH, Marciel KK, Grimley ME. Cystic fibrosis: a model for drug discovery and patient care. In: Roberts MC, Steele RG, editors. Handbook of pediatric psychology. The Guilford Press; New York, NY: 2009. pp. 271–286.
-
- Modi AC, Quittner AL. Barriers to treatment adherence for children with cystic fibrosis and asthma: what gets in the way? J Pediatr Psychol. 2006;31:846–858. - PubMed
-
- Quittner AL, Drotar D, Ievers-Landis CE. Changing adolescent adherence behaviors: the crucial role of family relationships; Proceedings of the annual meeting of the American Psychological Association; Honolulu, Hawai’i. 2004 Jul 28-Aug 1.2004.
-
- Ievers CE, Brown RT, Drotar D, Caplan D, Pishevar BS, Lambert RG. Knowledge of physician prescriptions and adherence to treatment among children with cystic fibrosis and their mothers. J Dev Behav Pediatr. 1999;20:335–343. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
